Navigation Links
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Date:9/5/2007

(trauma, surgery non-trauma and medical non-trauma) were performed similarly to the overall population.

Study Findings

There was no significant difference in the percentage of patients who received a RBC transfusion at day 29 between the PROCRIT and placebo groups (46% vs. 48.3%, p=0.34; relative risk 0.95, 95% confidence interval (CI), 0.85, 1.06). In addition, there was no difference between treatment groups in the total number of RBC units transfused through study day 42.

As noted by the authors, the most likely explanation for the lack of transfusion reduction was a change in transfusion practice. In two prior trials in critically ill patients, the PROCRIT group did achieve a reduction in RBC transfusions. In these studies, the mean pre-transfusion Hb concentration was 8.5 g/dL. In contrast in this trial, the mean pre- transfusion Hb concentration observed was 8.0 g/dL and the percentage of patients transfused was lower.

Mortality at study day 29 was significantly lower in the PROCRIT group (Kaplan-Meier (K-M) estimates: 8.5% vs. 11.4%, p=0.02). The mortality benefit with PROCRIT was most apparent in the trauma subgroup (K-M estimates: 3.5% vs. 6.6%, p=0.04). The mortality pattern at day 140 was similar for the overall group (K-M estimates: 14.2% vs. 16.8%, p=0.08) and the trauma subgroup (K-M estimates: 6.0% vs. 9.2%, p=0.08). The adjusted hazard ratios confirmed the mortality findings for trauma patients at days 29 (0.37, 95% CI, 0.19, 0.72) and 140 (0.40, 95% CI, 0.23, 0.69). The increase in Hb at day 29 was greater for patients who received PROCRIT (1.6 plus or minus 2.0 g/dL for patients receiving PROCRIT vs. 1.2 plus or minus 1.8 g/dL for patients receiving placebo, p<0.001).

As expected in a population of critically ill patients, adverse events and serious adverse events were frequent. A total of 690 (94.8%) PROCRIT patients and 680 (94.4%) placebo patients experienced at least one adverse event. Similarly, 44% of PROCRIT pa
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Calif. , Aug. 4, 2015  Rigel Pharmaceuticals, Inc. ... the second quarter and six months ended June 30, ... fostamatinib in ITP are progressing and we continue to ... Raul Rodriguez , president and chief executive officer of ... our other clinical programs, including evaluating fostamatinib for new ...
(Date:8/4/2015)... -- Dr. Keesha Ewers of The Functional ... flibanserin, or what is being touted as "pink ... female sexual desire back several decades. Diminished libido ... libido as a singular symptom with a singular ... Photo - http://photos.prnewswire.com/prnh/20150804/254705 ...
(Date:8/4/2015)... Aug. 4, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August ... Parker Meridien in New York . ... www.meipharma.com . A replay will be available approximately one ...
Breaking Medicine Technology:Rigel Announces Second Quarter 2015 Financial Results 2Rigel Announces Second Quarter 2015 Financial Results 3Rigel Announces Second Quarter 2015 Financial Results 4Rigel Announces Second Quarter 2015 Financial Results 5Rigel Announces Second Quarter 2015 Financial Results 6Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2
(Date:8/5/2015)... ... 05, 2015 , ... Employee Fiduciary has announced the launch ... Financial is a registered investment advisor, serving 401k and other types of retirement ... values and services , providing low-cost, fiduciary–grade investment advice to its clients. ...
(Date:8/5/2015)... ... ... opening of Chicago’s new elevated trail, the 606, has been getting a lot of press ... at Sedgebrook senior living community in Lincolnshire. Known as the Trailblazers, these robust hikers ... month to more distant places. When they read about the 606 on Chicago’s Northwest ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... Stelari introduces ... is reinventing yoga wear with their new line, The Earth’s Song. Combining fashion and ... and into your workout. Inspired by the Australian Outback, this collection is sure to ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... research funding, as well as awareness, education and support in order to reduce ... Aneurysm Foundation proudly announces this year it has awarded the most funding ...
(Date:8/4/2015)... ... August 05, 2015 , ... MONTICELLO, Fla. – After ... and the Tallahassee Memorial Hospital, this journey as a clinician allowed Dr. Barbara ... This journey equipped her to care for patients, families, friends and staff, and she ...
Breaking Medicine News(10 mins):Health News:Employee Fiduciary Announces Subsidiary 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3
... of the women in a national survey say that ... many of them arent sure if its safe. Yet ... oral contraceptive therapy to suppress menstruation is, in fact, ... by Kurt Barnhart MD, MSCE from the University of ...
... WASHINGTON, Oct. 3 The United States,Conference of ... H.,Palmer, today expressed shock and disbelief at President Bush,s ... Insurance Program known as,SCHIP. With his action, 10 million ... protection., "We are extremely disappointed because this is ...
... 3 The Executives, a support group,of nearly 500 ... to support the Los Angeles Jewish Home, has announced,noted ... the latest,speaker in the organization,s continuing breakfast programs featuring,high-profile ... to,Expect from the 5-4 Supreme Court." The gathering ...
... FACEP (E) Executive,Director American Public Health Association, ... from Georges C. Benjamin, MD, FACP, FACEP (E), ... deeply troubled that, despite overwhelming support from the,general ... Bush,today vetoed the Children,s Health Insurance Program (CHIP), ...
... parents who, while navigating a jam-packed childhood vaccine schedule, can ... pokes by his or her six-month checkup. , The ... no efficacy or safety is compromised when clinicians administer a ... tripling up three of the recommended shots to reduce the ...
... Yawei Ni, DelSite,s CSO, Will Detail Antigen ... of GelSite(R) Polymer, IRVING, Texas, Oct. 3 ... that Dr. Yawei Ni,Chief Scientific Officer of DelSite ... presentation titled "An Effective,Adjuvant Based on a Novel ...
Cached Medicine News:Health News:Differing attitudes found between women and doctors concerning menstrual suppression 2Health News:Mayors Express Frustration Over President Bush's Veto to SCHIP Legislation 2Health News:Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson 2Health News:APHA Deeply Troubled by Bush Veto of CHIP 2Health News:Combination vaccines okay for infants, study shows 2Health News:Combination vaccines okay for infants, study shows 3Health News:Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland 2Health News:Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland 3
... the entire series of time-tested Timeter® Classic ... needs of care providers and patients alike. ... You can see it in the craftsmanship. ... year after year. Every Timeter® Classic Flowmeter ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: